D
603233
vs
3088
D
603233
3088
Over the past 12 months, DaShenLin Pharmaceutical Group Co Ltd has outperformed MatsukiyoCocokara & Co, delivering a return of -3% compared to the MatsukiyoCocokara & Co's 11% drop.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
603233
3088
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
D
Intrinsic Value
27.05
CNY
Undervaluation 35%
Intrinsic Value
2 803.57
JPY
Undervaluation 16%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
17.53
CNY
|
|||||
|
MatsukiyoCocokara & Co
TSE:3088
|
2 346
JPY
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
603233, 3088
603233, 3088
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
Revenue
|
|||||||||||
|
|
MatsukiyoCocokara & Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
603233, 3088
603233, 3088
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
|||||||||
|
|
MatsukiyoCocokara & Co
TSE:3088
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
DaShenLin Pharmaceutical Group Co Ltd
34%
MatsukiyoCocokara & Co
35.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
Operating Margin
DaShenLin Pharmaceutical Group Co Ltd
6.8%
MatsukiyoCocokara & Co
7.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
Net Margin
DaShenLin Pharmaceutical Group Co Ltd
4.2%
MatsukiyoCocokara & Co
5.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
FCF Margin
DaShenLin Pharmaceutical Group Co Ltd
14.6%
MatsukiyoCocokara & Co
5.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
ROE
DaShenLin Pharmaceutical Group Co Ltd
16.1%
MatsukiyoCocokara & Co
10.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
ROA
DaShenLin Pharmaceutical Group Co Ltd
4.4%
MatsukiyoCocokara & Co
7.7%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
ROIC
DaShenLin Pharmaceutical Group Co Ltd
11.8%
MatsukiyoCocokara & Co
11%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
ROCE
DaShenLin Pharmaceutical Group Co Ltd
14.3%
MatsukiyoCocokara & Co
15.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd | ||||
|
|
MatsukiyoCocokara & Co | ||||
Solvency Comparison
D
DaShenLin Pharmaceutical Group C...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
603233, 3088
603233, 3088
Performance Gap
603233, 3088
603233, 3088
Performance By Year
603233, 3088
603233, 3088
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 603233 to other stocks
CLS
Clicks Group Ltd
C
More expensive
vs DaShenLin Pharmaceutical Group...
DCP
Dis-Chem Pharmacies Ltd
D
More expensive
vs DaShenLin Pharmaceutical Group...
WBA
Walgreens Boots Alliance Inc
Cheaper
vs DaShenLin Pharmaceutical Group...
RADL3
Raia Drogasil SA
More expensive
vs DaShenLin Pharmaceutical Group...
Select Stock to Compare
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
